Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
351.80
-14.40 (-3.93%)
May 14, 2025, 2:36 PM IDT

Enlivex Therapeutics Market Cap

Enlivex Therapeutics has a market cap or net worth of 84.14 million as of May 14, 2025. Its market cap has decreased by -18.93% in one year.

Market Cap
84.14M
Enterprise Value
2.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
351.80

Market Cap Chart

Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 84.14M, a decrease of -77.14%. That is a compound annual growth rate of -21.38%.

History

DateMarket Cap% Change
May 12, 202584.77M-9.54%
Dec 31, 202493.71M-48.18%
Dec 29, 2023180.84M-29.06%
Dec 30, 2022254.92M-28.46%
Dec 31, 2021356.33M-8.65%
Dec 31, 2020390.07M30.23%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Teva Pharmaceutical Industries 73.61B
Danel (Adir Yeoshua) 2.35B
Kamada 1.39B
Bait Bakfar 1.15B
Novolog (Pharm-Up 1966) 774.95M
SofWave Medical 722.24M
Ilex Medical 680.80M
BrainsWay 586.43M
Market Cap Rankings